Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (SHA:688621)

China flag China · Delayed Price · Currency is CNY
64.05
+2.05 (3.31%)
Mar 10, 2026, 3:00 PM CST
46.90%
Market Cap 7.00B
Revenue (ttm) 1.22B
Net Income (ttm) 196.08M
Shares Out 109.28M
EPS (ttm) 1.79
PE Ratio 35.78
Forward PE n/a
Dividend 0.16 (0.26%)
Ex-Dividend Date n/a
Volume 1,338,060
Average Volume 1,631,929
Open 62.87
Previous Close 62.00
Day's Range 62.02 - 64.56
52-Week Range 33.00 - 86.50
Beta 0.12
RSI 46.12
Earnings Date Apr 27, 2026

About SHA:688621

Beijing Sun-Novo Pharmaceutical Research Co., Ltd., a contract research company, engages in the research and development of drugs in China. The company operates external preparation platform that focuses on the research and development of new drugs and generic drugs for skin external preparations; children's clinical data bridging research center; pediatric drug research and development platform; pediatric drug delivery dosage research and development platform; respiratory tract drug delivery and topical preparation platforms; polypeptide and o... [Read more]

Sector Healthcare
Founded 2009
Employees 1,359
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688621
Full Company Profile

Financial Performance

In 2025, SHA:688621's revenue was 1.22 billion, an increase of 12.92% compared to the previous year's 1.08 billion. Earnings were 196.08 million, an increase of 10.53%.

Financial Statements

News

There is no news available yet.